ESMFold

Findings

• IC-1611Galactica-6.7b fails on protein secondary structure editing tasks, producing hit ratios below random mutation [context]
• IC-1611Galactica-6.7b fails on protein secondary structure editing tasks, producing hit ratios below random mutation [eval]
• IC-1612GPT-3.5-turbo achieves the best and most stable performance across all three drug types in conversational drug editing [eval]